cdmo.directory
← Compare landing

Altasciences vs ProBio

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/altasciences/probio

CategoryAltasciencesProBio
Listed sitebothboth
SummaryMid-size early phase CRO/CDMO in Canada and the U.S. offering preclinical safety testing, clinical pharmacology (Phase I–II), bioanalysis, research services, and manufacturing with integrated capabilities.ProBio is a leading global CDMO subsidiary of GenScript Biotech Corporation, providing end-to-end services for biologics and cell & gene therapy (CGT) from drug discovery through commercialization.
Services
  • Preclinical In Vivo Studies
  • GLP Toxicology
  • Safety Pharmacology
  • In Vitro Pharmacology
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Clinical Trial Services
  • Bioanalysis
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • Biostatistics & Statistical Programming
  • Data Management & eClinical
  • Medical Writing
  • Clinical Operations
  • Regulatory Affairs
  • In Vivo PK / PD Studies
  • Preclinical In Vitro Studies
  • Phase IV / Post-Marketing
  • In Vitro ADME / DMPK
  • Formulation Development
  • Stability Testing & Storage
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • In Vitro Pharmacology
  • Protein Engineering
  • Bioanalysis
  • Flow Cytometry Services
  • Immunogenicity Assays (ADA / NAb)
Modalities
  • Small Molecule
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • mRNA
  • Cell Therapy
  • Gene Therapy
  • Vaccine
  • AAV / Viral Vector Platform
Indications
  • Cardiovascular
  • Dermatology
  • Gastroenterology
  • Immunology
  • Infectious Disease
  • Metabolic
  • Neurology
  • Oncology
  • Ophthalmology
  • Psychiatry
  • Respiratory
  • Women's Health
  • Infectious Disease
Locations
  • Headquarters, Montreal, Quebec, Canada
  • Bioanalytical Laboratory, Laval, Quebec, Canada
  • Clinical Site, Montreal, Quebec, Canada
  • Clinical and Research Campus, Overland Park, Kansas, United States
  • Preclinical Testing, Everett, Washington, United States
  • Manufacturing and Analytical Services, Harleysville, Pennsylvania, United States
  • Preclinical Testing, Scranton, Pennsylvania, United States
  • Preclinical Testing, Columbia, Missouri, United States
  • Clinical Pharmacology, Cypress, California, United States
  • Preclinical Testing, Sacramento, California, United States
  • Laval, Laval, Quebec, Canada
  • Overland Park, Overland Park, Kansas, United States
  • Everett, Everett, Washington, United States
  • Harleysville, Harleysville, Pennsylvania, United States
  • Cypress, Cypress, California, United States
  • Scott Township, Scott Township, Pennsylvania, United States
  • Auxvasse, Auxvasse, Missouri, United States
  • Sacramento, Sacramento, California, United States
  • Canada, Canada, Canada
  • United States, United States, United States
  • Canada and U.S. operations
  • United States, United States
  • Netherlands, Netherlands
  • South Korea, South Korea
  • Hong Kong, Hong Kong, China
  • Shanghai, Shanghai, China
  • Nanjing, Nanjing, China
Certifications
  • FDA · Identifier: FDA inspection passed 2001
  • GLP · Identifier: GLP Compliant
  • GMP · Identifier: GMP Manufacturing
  • FDA · Identifier: US Food and Drug Administration
  • EMA · Identifier: European Medicines Agency
  • NMPA · Identifier: National Medical Products Administration
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.